Identification of biological properties of intralymphatic tumor related to the development of lymph node metastasis in lung adenocarcinoma

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Kirita, Keisuke ^a,b   Ishii, Genichiro ^a   Matsuwaki, Rie ^a   Matsumura, Yuki ^a   Umemura, Shigeki ^a   Matsumoto, Shingo ^a   Yoh, Kiyotaka ^a   Niho, Seiji ^a   Goto, Koichi ^a   Ohmatsu, Hironobu ^a   Ohe, Yuichiro ^a,b   Nagai, Kanji ^a   Ochiai, Atsushi ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 1; CADHERIN; ISOENZYME; MSR1 PROTEIN, HUMAN; RETINAL DEHYDROGENASE; SCAVENGER RECEPTOR A; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ADENOCARCINOMA; ADULT; AGED; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGY; LUNG TUMOR; LYMPH NODE METASTASIS; MACROPHAGE; MALE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CADHERINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOENZYMES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MACROPHAGES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETINAL DEHYDROGENASE; SCAVENGER RECEPTORS, CLASS A; SOXB1 TRANSCRIPTION FACTORS;

EID: 84893501411     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083537     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Devesa SS, Bray F, Vizcaino AP, Parkin DM (2005) International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 117: 294-299. (Pubitemid 41379403)
3. Kelsey CR, Marks LB, Hollis D, Hubbs JL, Ready NE, et al. (2009) Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients. Cancer 115: 5218-5227.
4. Luzzi L (2000) Assessing the prognostic value of the extent of mediastinal lymph node infiltration in surgically-treated non-small cell lung cancer (NSCLC). Lung Cancer 30.
5. Brechot JM, Chevret S, Charpentier MC, Appere de Vecchi C, Capron F, et al. (1996) Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival. Cancer 78: 2111-2118.
6. Matsumura Y, Ishii G, Aokage K, Kuwata T, Hishida T, et al. (2012) Morphophenotypic characteristics of intralymphatic cancer and stromal cells susceptible to lymphogenic metastasis. Cancer Sci 103: 1342-1347.
7. John D (2012) The Cancer Stem-Cell Hypothesis Its Emerging Roles in Lung Cancer Biology and Its Relevance for Future Therapy J Thorac Oncol 7.
8. Dimou A, Neumeister V, Agarwal S, Anagnostou V, Syrigos K, et al. (2012) Measurement of aldehyde dehydrogenase 1 expression defines a group with better prognosis in patients with non-small cell lung cancer. Am J Pathol 181: 1436-1442.
9. Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, et al. (2010) Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res 70: 10433-10444.
10. Li X, Wang J, Xu Z, Ahmad A, Li E, et al. (2012) Expression of sox2 and oct4 and their clinical significance in human non-small-cell lung cancer. Int J Mol Sci 13: 7663-7675.
11. Chunhacha P, Chanvorachote P (2012) Roles of caveolin-1 on anoikis resistance in non small cell lung cancer. Int J Physiol Pathophysiol Pharmacol 4: 149-155.
12. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454: 436-444.
13. Duda DG, Duyverman AM, Kohno M, Snuderl M, Steller EJ, et al. (2010) Malignant cells facilitate lung metastasis by bringing their own soil. Proc Natl Acad Sci U S A 107: 21677-21682.
14. Saijo T, Ishii G, Ochiai A, Hasebe T, Yoshida J, et al. (2007) Evaluation of extratumoral lymphatic permeation in non-small cell lung cancer as a means of predicting outcome. Lung Cancer 55: 61-66. (Pubitemid 46038881)
15. Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, et al. (2005) Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23: 8706-8712. (Pubitemid 46211514)
16. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, et al. (2008) Prognostic significance of the number of lymph node metastases in esophageal cancer. J Am Coll Surg 206: 239-246.
17. Vinh-Hung V, Verschraegen C, Promish DI, Cserni G, Van de Steene J, et al. (2004) Ratios of involved nodes in early breast cancer. Breast Cancer Res 6: R680-688.
18. Jonnalagadda S, Arcinega J, Smith C, Wisnivesky JP (2011) Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer. Cancer 117: 4724-4731.
19. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, et al. (2009) Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 69: 4116-4124.
20. Luo W, Li S, Peng B, Ye Y, Deng X, et al. (2013) Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelialmesenchymal transition in nasopharyngeal carcinoma. PLoS One 8: e56324.
21. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, et al. (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567. (Pubitemid 350056407)
22. Liebscher CA, Prinzler J, Sinn BV, Budczies J, Denkert C, et al. (2013) Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma. Hum Pathol.
23. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, et al. (2009) Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69: 3382-3389.
24. Prasmickaite L, Engesaeter BO, Skrbo N, Hellenes T, Kristian A, et al. (2010) Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma. PLoS One 5: e10731.
25. Okudela K (2013) Downregulation of ALDH1A1 expression in non-small cell lung carcinomas - its clinicopathologic and biological significance. Int J Clin Exp Pathol 6.
26. Hagemann T, Wilson J, Burke F, Kulbe H, Li NF, et al. (2006) Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J Immunol 176: 5023-5032.
27. Hao NB, Lu MH, Fan YH, Cao YL, Zhang ZR, et al. (2012) Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012: 948098.
28. Kawata M, Koinuma D, Ogami T, Umezawa K, Iwata C, et al. (2012) TGF-beta-induced epithelial-mesenchymal transition of A549 lung adenocarcinoma cells is enhanced by pro-inflammatory cytokines derived from RAW 264.7 macrophage cells. J Biochem 151: 205-216.
29. Fujisawa T, Rubin B, Suzuki A, Patel PS, Gahl WA, et al. (2012) Cysteamine suppresses invasion, metastasis and prolongs survival by inhibiting matrix metalloproteinases in a mouse model of human pancreatic cancer. PLoS One 7: e34437.
30. Xiang R, Liao D, Cheng T, Zhou H, Shi Q, et al. (2011) - Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. Br J Cancer 104: 1410-1417.
31. Singh S, Trevino J, Bora-Singhal N, Coppola D, Haura E, et al. (2012) EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer. Mol Cancer 11: 73.
32. Nakatsugawa M, Takahashi A, Hirohashi Y, Torigoe T, Inoda S, et al. (2011) SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity. Lab Invest 91: 1796-1804.
33. Sholl LM, Barletta JA, Yeap BY, Chirieac LR, Hornick JL, et al. (2010) - Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma. Am J Surg Pathol 34: 1193-1198.